Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05829863 · ClinicalTrials.gov registry record · NA
A Neuroimaging Approach to Advance Mechanistic Understanding of Tobacco Use Escalation Risk Among Young Adult African American Vapers
A NA study, sponsored by University of Georgia.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05829863 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 24 participants.
The verdict
NCT05829863, a NA study, has completed, sponsored by University of Georgia.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
60 young adult African American vapers who are not current smokers will participate in a baseline functional magnetic resonance imaging (fMRI) experiment, with 4 weekly follow-up surveys to gauge their tobacco use behaviors following the baseline scan. Baseline fMRI tasks will probe critical neurocognitive markers with high potential to account for individual differences in nicotine use prognosis and responsiveness to anti-vaping public service announcements (PSAs).
Interventions
- BEHAVIORAL educational message exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05829863
The ClinicalTrials.gov registry entry for NCT05829863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which educational message exposure is the first listed.
NCT05829863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05829863 about?
NCT05829863 is a clinical study titled "A Neuroimaging Approach to Advance Mechanistic Understanding of Tobacco Use Escalation Risk Among Young Adult African American Vapers". 60 young adult African American vapers who are not current smokers will participate in a baseline functional magnetic resonance imaging (fMRI) experiment, with 4 weekly follow-up surveys to gauge their tobacco use behaviors following the baseline scan. Baseline fMRI tasks will probe critical neuroco...
What is the current status of trial NCT05829863?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-05-01. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT05829863?
The interventions under investigation include: educational message exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT05829863?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.